openPR Logo
Press release

Research News: Global AI-based Clinical Trial Solution Market Size Analysis 2020 due to COVID-19 Impact

10-10-2020 08:18 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: GLOBAL INFO RESEARCH

Research News: Global AI-based Clinical Trial Solution Market

This report also researches and evaluates the impact of Covid-19 outbreak on the AI-based Clinical Trial Solution industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on AI-based Clinical Trial Solution and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

GLOBAL INFO RESEARCH added a new research report to its exhaustive repository. The research report, titled [Global AI-based Clinical Trial Solution Market 2020 by Company, Regions, Type and Application, Forecast to 2025], presents an unbiased approach at understanding the market trends and dynamics. Analysts have studied the historical data pertaining to the market and compared it to the current market trends to paint an object picture of the market’s trajectory. The report includes SWOT analysis and Porter’s five forces analysis to give the readers an in-depth assessment of the various factors likely to drive and restrain the overall market.

Both the market measurement tools offer evaluation of the strengths, weaknesses, opportunities, and threats. It also elucidates the bargaining power of suppliers and buyers. The report studies the ongoing political scenarios that are expected to dictate the pricing and import and export in the global AI-based Clinical Trial Solution market. Furthermore, it also explains the lucrative opportunities present in the overall market that players can focus on to make their mark.

Click to view the full report TOC, figure and tables:  https://www.globalinforesearch.com/Global-AI-based-Clinical-Trial-Solution_p502346.html

The following Companies as the Key Players in the Global AI-based Clinical Trial Solution Market Research Report:

AiCure
Median Technologies
Saama Technologies
Antidote
Innoplexus
Deep Lens
Phesi
Deep 6 AI
Trials.ai
Mendel.ai
Deloitte
Innoplexus
IBM

Regions Covered in the Global AI-based Clinical Trial Solution Market:

The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand,  India, Indonesia, and Australia)

The scope of the Report:

The research report on AI-based Clinical Trial Solution includes segmentation of the market. The global AI-based Clinical Trial Solution market is segmented on the basis of application, services, end users, and region. Each segment includes a detailed explanation of the factors that are likely to drive and restrain it. In addition, the research report also provides an assessment of the emerging trends in the global market that will benefit each segment during the forecast years.

Analysts have also studied the competitive landscape present in the global AI-based Clinical Trial Solution market. The chapter on company profiles includes an analysis of the key players operating in the global AI-based Clinical Trial Solution market. It provides vital information about the strategic initiatives about the companies in the market and their outlook for the forecast years.

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global AI-based Clinical Trial Solution market

Chapter 2: Evaluating the leading manufacturers of the global AI-based Clinical Trial Solution market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales  

Chapter 4: Presenting global AI-based Clinical Trial Solution market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Table of Content

1 AI-based Clinical Trial Solution Market Overview
1.1 Product Overview and Scope of AI-based Clinical Trial Solution
1.2 Classification of AI-based Clinical Trial Solution by Type
1.2.1 Global AI-based Clinical Trial Solution Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global AI-based Clinical Trial Solution Revenue Market Share by Type in 2019
1.2.3 Artificial Narrow Intelligence
1.2.4 Artificial General Intelligence
1.2.5 Artificial Super Intelligence
1.3 Global AI-based Clinical Trial Solution Market by Application
1.3.1 Overview: Global AI-based Clinical Trial Solution Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drug Discovery
1.3.3 Drug Manufacturing
1.3.4 Drug Marketing
1.3.5 Diagnosis and Treatment
1.3.6 Clinical Trials
1.4 Global AI-based Clinical Trial Solution Market by Regions
1.4.1 Global AI-based Clinical Trial Solution Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of AI-based Clinical Trial Solution (2015-2025)
1.4.3 North America (USA, Canada and Mexico) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) AI-based Clinical Trial Solution Status and Prospect (2015-2025)
2 Company Profiles
2.1 AiCure
2.1.1 AiCure Details
2.1.2 AiCure Major Business
2.1.3 AiCure SWOT Analysis
2.1.4 AiCure Product and Services
2.1.5 AiCure AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.2 Median Technologies
2.2.1 Median Technologies Details
2.2.2 Median Technologies Major Business
2.2.3 Median Technologies SWOT Analysis
2.2.4 Median Technologies Product and Services
2.2.5 Median Technologies AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.3 Saama Technologies
2.3.1 Saama Technologies Details
2.3.2 Saama Technologies Major Business
2.3.3 Saama Technologies SWOT Analysis
2.3.4 Saama Technologies Product and Services
2.3.5 Saama Technologies AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.4 Antidote
2.4.1 Antidote Details
2.4.2 Antidote Major Business
2.4.3 Antidote SWOT Analysis
2.4.4 Antidote Product and Services
2.4.5 Antidote AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.5 Innoplexus
2.5.1 Innoplexus Details
2.5.2 Innoplexus Major Business
2.5.3 Innoplexus SWOT Analysis
2.5.4 Innoplexus Product and Services
2.5.5 Innoplexus AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.6 Deep Lens
2.6.1 Deep Lens Details
2.6.2 Deep Lens Major Business
2.6.3 Deep Lens Product and Services
2.6.4 Deep Lens AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.7 Phesi
2.7.1 Phesi Details
2.7.2 Phesi Major Business
2.7.3 Phesi Product and Services
2.7.4 Phesi AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.8 Deep 6 AI
2.8.1 Deep 6 AI Details
2.8.2 Deep 6 AI Major Business
2.8.3 Deep 6 AI Product and Services
2.8.4 Deep 6 AI AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.9 Trials.ai
2.9.1 Trials.ai Details
2.9.2 Trials.ai Major Business
2.9.3 Trials.ai Product and Services
2.9.4 Trials.ai AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mendel.ai
2.10.1 Mendel.ai Details
2.10.2 Mendel.ai Major Business
2.10.3 Mendel.ai Product and Services
2.10.4 Mendel.ai AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.11 Deloitte
2.11.1 Deloitte Details
2.11.2 Deloitte Major Business
2.11.3 Deloitte Product and Services
2.11.4 Deloitte AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.12 Innoplexus
2.12.1 Innoplexus Details
2.12.2 Innoplexus Major Business
2.12.3 Innoplexus Product and Services
2.12.4 Innoplexus AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
2.13 IBM
2.13.1 IBM Details
2.13.2 IBM Major Business
2.13.3 IBM Product and Services
2.13.4 IBM AI-based Clinical Trial Solution Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global AI-based Clinical Trial Solution Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 AI-based Clinical Trial Solution Players Market Share
3.2.2 Top 10 AI-based Clinical Trial Solution Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global AI-based Clinical Trial Solution Revenue and Market Share by Regions
4.2 North America AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.3 Europe AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.5 South America AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5 North America AI-based Clinical Trial Solution Revenue by Countries
5.1 North America AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
5.2 USA AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5.3 Canada AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
5.4 Mexico AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6 Europe AI-based Clinical Trial Solution Revenue by Countries
6.1 Europe AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
6.2 Germany AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.3 UK AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.4 France AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.5 Russia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
6.6 Italy AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7 Asia-Pacific AI-based Clinical Trial Solution Revenue by Regions
7.1 Asia-Pacific AI-based Clinical Trial Solution Revenue by Regions (2015-2020)
7.2 China AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.3 Japan AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.4 Korea AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.5 India AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
8 South America AI-based Clinical Trial Solution Revenue by Countries
8.1 South America AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
8.2 Brazil AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
8.3 Argentina AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue AI-based Clinical Trial Solution by Countries
9.1 Middle East & Africa AI-based Clinical Trial Solution Revenue by Countries (2015-2020)
9.2 Saudi Arabia AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.3 UAE AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.4 Egypt AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
9.5 South Africa AI-based Clinical Trial Solution Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global AI-based Clinical Trial Solution Revenue and Market Share by Type (2015-2020)
10.2 Global AI-based Clinical Trial Solution Market Forecast by Type (2019-2024)
10.3 Artificial Narrow Intelligence Revenue Growth Rate (2015-2025)
10.4 Artificial General Intelligence Revenue Growth Rate (2015-2025)
10.5 Artificial Super Intelligence Revenue Growth Rate (2015-2025)
11 Global AI-based Clinical Trial Solution Market Segment by Application
11.1 Global AI-based Clinical Trial Solution Revenue Market Share by Application (2015-2020)
11.2 AI-based Clinical Trial Solution Market Forecast by Application (2019-2024)
11.3 Drug Discovery Revenue Growth (2015-2020)
11.4 Drug Manufacturing Revenue Growth (2015-2020)
11.5 Drug Marketing Revenue Growth (2015-2020)
11.6 Diagnosis and Treatment Revenue Growth (2015-2020)
11.7 Clinical Trials Revenue Growth (2015-2020)
12 Global AI-based Clinical Trial Solution Market Size Forecast (2021-2025)
12.1 Global AI-based Clinical Trial Solution Market Size Forecast (2021-2025)
12.2 Global AI-based Clinical Trial Solution Market Forecast by Regions (2021-2025)
12.3 North America AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.4 Europe AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.6 South America AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa AI-based Clinical Trial Solution Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

About Us:

GlobaI Info Research(GIR) is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

Contact US

Global Info Research

E-mail: report@globalinforesearch.com

Tel:  +86-13660489451     00852-58197708(HK)

Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG

Website: http://www.globalinforesearch.com

 

Contact US

Global Info Research

E-mail: report@globalinforesearch.com

Tel:  +86-13660489451     00852-58197708(HK)

Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG

Website: http://www.globalinforesearch.com

 

GlobaI Info Research(GIR) is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research News: Global AI-based Clinical Trial Solution Market Size Analysis 2020 due to COVID-19 Impact here

News-ID: 2154511 • Views: 493

More Releases from GLOBAL INFO RESEARCH

Bookend Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Bookend Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Bookend Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515166/bookend Market Overview The Bookend
Global Nanocrystalline Soft Magnetic Materials Market Overview Report by 20 …
Scope of the Report: The global Nanocrystalline Soft Magnetic Materials market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 367.3 million by 2025, from USD 248.8 million in 2019. Market segmentation Nanocrystalline Soft Magnetic Materials market is split by Type and by Application. For the period 2015-2025,
Global Moxibustion Instruments Market Status and Outlook (2020-2025)
Global Info Research offers a latest published report on Moxibustion Instruments Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Moxibustion Instruments Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515155/moxibustion-instruments Market
Guitar Strap Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Guitar Strap Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Guitar Strap Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/reports/515154/guitar-strap Market

All 5 Releases


More Releases for Trial

Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Global Clinical Trial Imaging Market
Global Clinical Trial Imaging Market is expected to reach USD 1297.39 Million by 2024 from USD 773.2 Million in 2016 at CAGR of 6.68% (Detailed analysis of the market CAGR is provided in the report). Global Clinical Trial Imaging Market is segmented by product & services, imaging modality, end user, and geography. Imaging Modality segment is classified as magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound and others. Computed Tomography
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials